| 000 | 01491 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250516012607.0 | ||
| 264 | 0 | _c20120524 | |
| 008 | 201205s 0 0 eng d | ||
| 022 | _a1755-5922 | ||
| 024 | 7 |
_a10.1111/j.1755-5922.2010.00248.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aReny, Jean-Luc | |
| 245 | 0 | 0 |
_aPoor responsiveness to antiplatelet drugs in acute coronary syndromes: clinical relevance and management. _h[electronic resource] |
| 260 |
_bCardiovascular therapeutics _cFeb 2012 |
||
| 300 |
_ae41-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAcute Coronary Syndrome _xblood |
| 650 | 0 | 4 |
_aAngioplasty, Balloon, Coronary _xadverse effects |
| 650 | 0 | 4 |
_aDrug Resistance _xgenetics |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aGuideline Adherence |
| 650 | 0 | 4 |
_aHemorrhage _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBonvini, Robert F | |
| 700 | 1 | _aBonvini, John M | |
| 700 | 1 | _aRoffi, Marco | |
| 700 | 1 | _aFontana, Pierre | |
| 773 | 0 |
_tCardiovascular therapeutics _gvol. 30 _gno. 1 _gp. e41-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1755-5922.2010.00248.x _zAvailable from publisher's website |
| 999 |
_c20371245 _d20371245 |
||